Exercise may improve outcomes for patients with hematologic cancers
the ONA take:
A 12-week exercise rehabilitation program resulted in improvements in cancer-related fatigue and additional outcomes in patients with hematologic cancer following treatment, a new study published online ahead of print in the journal Supportive Care in Cancer has shown.
Because patients with hematologic malignancies exhibit significant physical deconditioning and psychological distress after treatment, researchers sought to evaluate the efficacy of a 12-week exercise rehabilitation on cancer-related fatigue and related outcomes in these patients following treatment.
Researchers enrolled 37 patients and randomly assigned them 1:1 to participate in the 12-week exercise rehabilitation or usual care.
The rehabilitation consisted of tailored exercise programs comprising aerobic and resistance exercises performed three times weekly for 12 weeks in local gyms and clinics. Those in the usual care group were offered a delayed, tailored 12-week exercise program after the initial study period.
The study demonstrated that the 12-week exercise rehabilitation program resulted in significant improvement in cancer-related fatigue, cardiovascular fitness, quality of life, muscle strength, and body composition. The delayed 12-week exercise program also showed similar significant improvements in patient outcomes.
A 12-week exercise rehabilitation program resulted in improvements in cancer-related fatigue.
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Impact of Prostate Cancer Diagnosis, Treatment Choice on Quality of Life
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- Refined Equation May Obviate Oncotype DX in Breast Cancer Treatment Decisions
- Risk Factors for Brain Metastases in HER2+ Breast Cancer Identified in Analysis
- Intermediate Oncotype DX Scores Prognostic of OS in Early-stage Breast Cancer
- Colorectal Cancer and Dietary Fiber: Source Is More Important Than Amount
- Reduced Delayed Intensification Impacts Risk of Pediatric ALL Relapse
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|